Skip to content

Ticagrelor

Ticagrelor (Brilinta) is a blood thinner used to prevent blood clots in people with acute coronary syndrome or after a heart attack. This page lists the one formulation available in this catalogue.

Brilinta

Acute Coronary Syndrome, Myocardial Infarction

90mg

Ticagrelor tablets for acute coronary syndrome and heart attack. It stops platelets from sticking together by blocking the signals that activate them.

From$3.11/ tabletView

Key points

  • Ticagrelor is an antiplatelet medicine that prevents blood clots by stopping platelets from clumping together.
  • The only formulation listed is a 90 mg tablet, the originator brand Brilinta marketed by AstraZeneca.

What Ticagrelor is used for

The medicine ticagrelor is listed for acute coronary syndrome and myocardial infarction. It is used to reduce the risk of blood clots in people who have these conditions.

Further reading